Risk factor
Strong trading liquidity
Profitability factor
Undervalued vs peers
About
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, undervalued on P/FCF.
Target Price
The average target price of DVA is 147 and suggests 3% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to decrea
Buy
Sell